How Much of the U.S. Cannabis Growth Will Come From Recreational Use Market
Palm Beach, FL – (January 8, 2019) – Predictions for the worldwide growth of the cannabis industry show much optimism for both the recreational and medicinal cannabis segments. Worldwide projections see the North American market relying on recreational sales while the European markets will be in the medical arena. As recently reported in article published on FORBES, the North America’s cannabis market will go from $9.2 billion in 2017 to $47.3 billion in 2027. The article stated “According to Arcview Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry will see much progress around the globe. Spending on legal cannabis worldwide is expected to hit $57 billion by 2027. The adult-use (recreational) market will cover 67% of the spending; medical marijuana will take up the remaining 33%.” Active companies in the Cannabis market this week include Cannabis Strategic Ventures, Inc. (OTC:NUGS), Neptune Wellness Solutions Inc. (NASDAQ:NEPT), Aphria Inc. (NYSE:APHA) (TSX:APHA), Leafbuyer Technologies, Inc. (OTC:LBUY), KushCo Holdings, Inc. (OTC:KSHB).
Also according to the FORBES article, the largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later. The largest growth spread, however, is predicted within the rest-of-world markets, from $52 million spent in 2017 to a projected $2.5 billion in 2027. The main difference between the U.S. and European cannabis markets is that in the U.S., recreational use will dominate sales. With a budget of $1.3 trillion in health care spending, European government-subsidized health care systems will bring the medical cannabis market to dominate Europe and become the largest medical marijuana market in the world.
Cannabis Strategic Ventures, Inc. (OTCPK:NUGS) BREAKING NEWS: Cannabis Strategic Ventures today announces that it has submitted its application to uplist to the OTCQB® Venture Market. The uplisting criteria require the Company to file financial and other reports to the Securities & Exchange Commission in a timely manner in addition to undergoing an extensive verification and certification process. The Company believes it meets all of the requirements for a successful uplisting.
“We are excited to submit our application to the OTCQB Tier, which has more stringent reporting standards and compliance requirements, and requires companies to maintain a minimum share prices and to be fully reporting,” states Cannabis Strategic Ventures CEO Simon Yu. “We have many new initiatives planned 2019 and we are managing our business operations for growth. This uplisting is designed to demonstrate to our investors and to the marketplace that Cannabis Strategic Ventures is well-prepared for the future.”
Companies that uplist to higher tiers typically provide investors with increased transparency, which can result in greater awareness and liquidity. For Cannabis Strategic Ventures, uplisting also supports the Company’s broader growth strategy, which includes its recent acquisitions of several hemp-derived cannabidiol (“CBD”) brands in the cannabis and ancillary sectors, including The Asher House Wellness, Fitamins, LYXR. The Company is also targeting several hard assets consisting of various growth facilities.
Cannabis Strategic Ventures believes cannabis industry growth will continue at a rapid rate, fueled by medical and recreational legalizations, as well as the recent passage of the 2018 Farm Bill. A 2018 report by Grandview Research predicts the global industrial hemp market size to reach US$10.6 billion by 2025, an amount propelled by increased demand for high-quality cosmetics, personal care products, protein supplements, and other health food products. Read this and more news for Cannabis Strategic Ventures at: https://www.financialnewsmedia.com/news-nugs
Other recent developments and major influences in the cannabis industry include:
Neptune Wellness Solutions Inc. (NASDAQ:NEPT) closed up over 12% on Monday at $3.25 trading over 2.6 Million shares by the market close. The Company announce this week that it has received its license to process cannabis from Health Canada. “In 2017, we embarked upon a new strategic vision to position the Company in growth markets such as the legal cannabis market and to become a global leader in cannabis extraction, purification and formulation of value-added differentiated products. Since then, we have executed a carefully-planned roadmap to ready our significant manufacturing capacity for production, secure multi-year commercial contracts with great companies like Canopy Growth, and expand our strategic relationships, recently beginning a collaboration agreement with Lonza, a global market leader for the production of unique value-added capsules.
Aphria Inc. (NYSE:APHA) (TSX:APHA) closed up over 6% on Monday at $6.41 trading over 6.024 Million shares by the market close. The Company is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment.
Leafbuyer Technologies, Inc. (OTCQB:LBUY) closed up over 8% on Monday trading over 750,000 shares. Leafbuyer announced this week it launched Phase One of its multiphase blockchain initiative on December 20, 2018. This first phase integrates with the Company’s loyalty platform, Leafbuyer Loyalty. This launch creates the bridge for cannabis consumers to eventually complete monetary transactions electronically with dispensaries and product companies. Now, within the Leafbuyer Loyalty application, consumers can choose to create their own blockchain wallet, called the Leafbuyer Wallet. Immediately, when a consumer creates a Leafbuyer Wallet account at a participating dispensary, a link is sent through SMS to their mobile device.
KushCo Holdings, Inc. (OTCQB:KSHB) closed up over 3% on Monday at $6.01 trading over 1.1 Million shares by the market close. KushCo Holdings, Inc., the parent company of innovative industry leaders such as Kush Supply Co., Kush Energy, The Hybrid Creative, and Koleto Packaging Solutions, which provide a range of services and products for a variety of industries including the regulated cannabis and CBD industries, recently announced it will issue its fiscal first quarter 2019 results press release on January 8, 2019 after U.S. markets close. The company will also host a conference call on Tuesday, January 8, 2019 at 4:30 PM Eastern Time.
Participant Dial-In Numbers:
Toll / International: 1-856-344-9290
*Participants should request the KushCo Holdings Earnings Call or provide confirmation code 9657030
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty five hundred dollars for news coverage of the current press releases issued by Cannabis Strategic Ventures, Inc by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact email: email@example.com – +1(561)325-8757